NCT03000647

Brief Summary

The aim of the study is to evaluate the effectiveness of guided versus non guided pelvic floor exercises for urinary incontinence in patients with Relapsing-Remitting Multiple Sclerosis

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2015

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2015

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 14, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 22, 2016

Completed
Last Updated

July 11, 2019

Status Verified

March 1, 2018

Enrollment Period

1 year

First QC Date

December 14, 2016

Last Update Submit

July 9, 2019

Conditions

Keywords

Pelvic floor muscle exerciseSupervisionPhysiotherapy

Outcome Measures

Primary Outcomes (1)

  • Decrease in the number of urinary leakages from baseline

    Difference in the mean number of leakages (Registered for 3 days with a bladder diary)

    12 weeks

Secondary Outcomes (5)

  • Decrease of urinary incontinence severity from baseline

    4,8 and 12 weeks

  • Change in quality of life from baseline

    4,8 and 12 weeks

  • Decrease in the number of urinary leakages from baseline

    4 and 8 weeks

  • Lower urinary tract symptoms from baseline

    4,8 and 12 weeks

  • Adherence

    12 weeks

Study Arms (2)

Guided Pelvic floor exercises

ACTIVE COMPARATOR

Pelvic floor exercises guided by a physiotherapist

Procedure: Pelvic floor exercises guided by a physiotherapist

Non-guided pelvic floor exercises

ACTIVE COMPARATOR

Pelvic floor exercises not guided

Procedure: Non guided pelvic floor exercises

Interventions

Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day and once a week they check it with a physiotherapist (this day only they do it twice at home)

Guided Pelvic floor exercises

Subjects perform two types of contractions of the pelvic floor in two different positions 3 times a day. They do not attend to meetings with a physiotherapist

Non-guided pelvic floor exercises

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with Relapsing-Remitting Multiple Sclerosis
  • Diagnosed with Urinary Incontinence
  • Minimental Sate Examination (MMSE) scale: More than 24
  • Expanded Disability Status Scale (EDSS) scale: Bladder function 0-4; EDSS 0-6,5
  • Willing to participate in the study
  • Having Signed an informed consent

You may not qualify if:

  • Diagnosed with another neurological disease
  • Diagnosed with kidney diseases
  • Having a Relapse of the disease in the last 6 months
  • In Women: Pregnancy os postpartum \< 6 months
  • Having gone through surgery for urinary incontinence or prolapses or prostate diseases
  • Having gone through other treatment for pelvic floor
  • MMSE scale: Under 24
  • EDSS scale: Bladder function 5-6 or not knowing; EDSS 7-10
  • ICIQ-SF scale: Severity 19-21
  • Not willing to participate or sign the informed consent form or not able to understand the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital General de Villalba

Villalba, Madrid, 28400, Spain

Location

Related Publications (6)

  • Quarto G, Autorino R, Gallo A, De Sio M, D'Armiento M, Perdona S, Damiano R. Quality of life in women with multiple sclerosis and overactive bladder syndrome. Int Urogynecol J Pelvic Floor Dysfunct. 2007 Feb;18(2):189-94. doi: 10.1007/s00192-006-0131-9. Epub 2006 May 13.

    PMID: 16699915BACKGROUND
  • Gilpin SA, Gilpin CJ, Dixon JS, Gosling JA, Kirby RS. The effect of age on the autonomic innervation of the urinary bladder. Br J Urol. 1986 Aug;58(4):378-81. doi: 10.1111/j.1464-410x.1986.tb09089.x.

    PMID: 3756405BACKGROUND
  • Lucio AC, Campos RM, Perissinotto MC, Miyaoka R, Damasceno BP, D'ancona CA. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis. Neurourol Urodyn. 2010 Nov;29(8):1410-3. doi: 10.1002/nau.20941.

    PMID: 20976816BACKGROUND
  • De Ridder D, Vermeulen C, Ketelaer P, Van Poppel H, Baert L. Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg. 1999 Mar;99(1):61-4.

    PMID: 10218095BACKGROUND
  • Litwiller SE, Frohman EM, Zimmern PE. Multiple sclerosis and the urologist. J Urol. 1999 Mar;161(3):743-57.

    PMID: 10022678BACKGROUND
  • Perez DC, Chao CW, Jimenez LL, Fernandez IM, de la Llave Rincon AI. Pelvic floor muscle training adapted for urinary incontinence in multiple sclerosis: a randomized clinical trial. Int Urogynecol J. 2020 Feb;31(2):267-275. doi: 10.1007/s00192-019-03993-y. Epub 2019 Jun 10.

MeSH Terms

Conditions

Multiple Sclerosis, Relapsing-RemittingUrinary Incontinence

Condition Hierarchy (Ancestors)

Multiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Denise Cuevas, BSc

    Universidad Rey Juan Carlos

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2016

First Posted

December 22, 2016

Study Start

October 1, 2015

Primary Completion

October 1, 2016

Study Completion

October 1, 2016

Last Updated

July 11, 2019

Record last verified: 2018-03

Data Sharing

IPD Sharing
Will not share

Locations